Biosion, Inc. 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-09 08:59 am Purchase | 2025-12-09 | 13G | ACLARIS THERAPEUTICS INC ACRS | Biosion, Inc. | 11,281,950 9.400% | 11,281,950 (New Position) | Filing |